Where does Navega Therapeutics's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Navega Therapeutics's 1 recorded funding rounds.

Premier Alternatives

Navega Therapeutics

San Diego, CA · Founded 2018 · Privately Held (backing)

Developer of gene therapies designed to treat chronic pain and tackle the opioid epidemic. Navega Therapeutics is based in San Diego, CA and was founded in 2018. It has raised $2.4 million across 1 recorded round; the latest was a $1.3 million seed round in Jan 2026.

Last price · $/share

—

Implied valuation

—

Total raised

$2.4M

Last round

Seed Round

Jan 2026

Cap table — not yet on record

Navega Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Free account

More of Navega Therapeutics with a free account

·The complete investor list: 13 names
·Watch Navega Therapeutics: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Frequently asked about Navega Therapeutics

Where does Navega Therapeutics's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Navega Therapeutics's 1 recorded funding rounds.